Frank G Angella

Title: Frank G Angella: Innovator in Therapeutic Monitoring

Introduction

Frank G Angella is a notable inventor based in Singapore, SG. He has made significant contributions to the field of therapeutic monitoring through his innovative patent. With a focus on improving animal health, Angella's work is essential for advancing veterinary medicine.

Latest Patents

Angella holds a patent for a method titled "Marking of orally ingested products." This method involves monitoring a therapeutic regimen in an animal by providing a therapeutic compound along with a detectable compound. The detectable compound passes into the bloodstream, excretory system, or other tissues in detectable form. After a specified period, a sample of the fluid or tissue is collected, and the detectable compound or its metabolite is measured. This innovative approach enhances the ability to track the effectiveness of treatments in animals.

Career Highlights

Angella's career is marked by his dedication to improving animal health through innovative solutions. His work at Biocode, Inc. has positioned him as a key player in the field of veterinary therapeutics. His patent reflects his commitment to advancing methodologies that benefit both animals and their caretakers.

Collaborations

Angella collaborates with esteemed colleagues, including James H Rittenburg and Michael G Pappas. These partnerships foster a collaborative environment that enhances the development of innovative solutions in therapeutic monitoring.

Conclusion

Frank G Angella's contributions to the field of veterinary medicine through his patent demonstrate his commitment to innovation and animal health. His work continues to pave the way for advancements in therapeutic monitoring.